Adverum Biotechnologies, Inc. (ADVM)
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Address
100 CARDINAL WAY
REDWOOD CITY, CA 94063
Founded
2006
Number of Employees
121
Website
http://www.adverum.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)